Researchers have identified a method to enhance the effectiveness of a promising cancer treatment. They found that modifying ...

Researchers found that bioengineered CAR-T cells when mixed with other immune cells can "donate" proteins, suggesting ...

Within a large group of more than 700 patients treated with CAR T cell therapy, researchers found no evidence that the ...

Stationed within the meninges, squads of immune cells lie in wait, ready to unleash an inflammatory assault within the brain if needed. Holding these trigger-happy troops back during peacetime falls ...

A new way to grow T cells in the lab enables them to live longer and better destroy cancer cells in a mouse model of melanoma ...

In this article, Cerba dives into CAR+ T-cell therapy, from patient treatment to solutions for minimal residual disease (MRD) ...

In a commercial that aired during the first quarter of today’s game, the Bellevue, Wash.-based wireless carrier touted the beta availability of T-Mobile Starlink, a collaboration between T-Mobile and ...

Despite the powerful cancer-fighting capabilities of treatments based on CAR-T cells to fight a patient’s cancer, one key challenge is getting these treatments to more patients.

A major limitation of this type of CAR T cell therapy, called autologous therapy, is that the cells are taken from the patient and must be custom-made into a treatment. This requires patients to wait ...

T-Mobile Starlink service will offer free direct-to-cell satellite coverage for all registrations until July, even to customers from rival carriers.

A new advance may make it possible to use off-the-shelf CAR T cells provided by healthy donors. The new approach studied in mice equipped CAR T cells with the viral protein Nef.